New agent reduces PTH levels in hemodialysis patients with secondary hyperparathyroidism

News
Article

New agent reduces PTH levels in hemodialysis patients with secondary hyperparathyroidism.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.